Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia. Cancer. 1985 Aug 01; 56(3):443-9.
View in:
PubMed
subject areas
Acute Disease
Adult
Aged
Bone Marrow
Cytarabine
Dose-Response Relationship, Drug
Female
Humans
Injections, Subcutaneous
Leukemia
Leukemia, Myeloid
Male
Middle Aged
Preleukemia
authors with profiles
Richard A. Larson